The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Solovieva E.Yu.

Pirogov Russian National Research Medical University

Vorobeva O.V.

Chuvash state university named after I.N. Ulyanov

Fateeva V.V.

Sechenov First Moscow State Medical University (Sechenov University);
OOO «NPF «MATERIA MEDICA HOLDING»

Skipetrova L.A.

Center for Speech Pathology and Neurorehabilitation

Imaging of brain activity using fMRI in a patient with subjective cognitive decline

Authors:

Solovieva E.Yu., Vorobeva O.V., Fateeva V.V., Skipetrova L.A.

More about the authors

Read: 2278 times


To cite this article:

Solovieva EYu, Vorobeva OV, Fateeva VV, Skipetrova LA. Imaging of brain activity using fMRI in a patient with subjective cognitive decline. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(4):125‑129. (In Russ.)
https://doi.org/10.17116/jnevro2023123041125

Recommended articles:
Gender aspe­cts of atte­ntion defi­cit hype­ractivity diso­rder. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):70-75

References:

  1. Yakhno NN, Zakharov VV, Koberskaya NN, et al. «Intentional» (subjective and mild) cognitive disorders. Neurological Journal. 2017;22(4):198-204. (In Russ.).
  2. Zakharov VV, Kabaeva AR. Non-dementia cognitive impairment: subjective, mild and moderate. Nervous Diseases. 2017;4:3-9. (In Russ.).
  3. Tabeeva GR. Cognitive disorders in depression and new targets for therapy. Effective Pharmacotherapy. 2018;20:28-37. (In Russ.).
  4. Viviano RP, Damoiseaux JS. Functional neuroimaging in subjective cognitive decline: current status and a research path forward. Alz Res Therapy. 2020;12:23.  https://doi.org/10.1186/s13195-020-00591-9
  5. Koberskaya NN, Mkhitaryan EA, Lokshina AB, Grishina DA. Predement cognitive disorders. Russian Journal of Geriatric Medicine. 2022;(1):48-57. (In Russ.). https://doi.org/10.37586/2686-8636-1-2022-48-57
  6. Studart A. Neto, Nitrini R. Subjective cognitive decline: The first clinical manifestation of Alzheimer’s disease? Dement Neuropsychol. 2016;10(3):170-177.  https://doi.org/10.1590/S1980-5764-2016DN1003002
  7. Zetterberg H, Schott JM. Objectifying Subjective Cognitive Decline The Prognostic Role of Alzheimer Biomarkers. Neurology. 2022;99(17):735-736.  https://doi.org/10.1212/WNL.0000000000201172
  8. Liew TM. Subjective cognitive decline, anxiety symptoms, and the risk of mild cognitive impairment and dementia. Alz Res Therapy. 2020;12:107.  https://doi.org/10.1186/s13195-020-00673-8
  9. Sun Y, Dai ZJ, Li YX, et al. Subjective cognitive decline: mapping functional and structural brain changes-a combined resting-state functional and structural MR imaging study. Radiology. 2016;281(1):185-192.  https://doi.org/10.1148/radiol.2016151771
  10. Wen C, Hu H, Ou YN. Risk factors for subjective cognitive decline: the CABLE study. Transl Psychiatry. 2021;11:576.  https://doi.org/10.1038/s41398-021-01711-1
  11. van Harten AC, Mielke MM, Swenson-Dravis DM, et al. Subjective cognitive decline and risk of MCI: the Mayo Clinic Study of Aging. Neurology. 2018;91:300-312.  https://doi.org/10.1212/WNL.0000000000005863
  12. Morozova SN, Kremneva EI, Gadzhieva ZSh, et al. Determination of the effectiveness of using the count as an fMRI paradigm in the study of functional relationships in the norm to assess the control functions of the brain. Medical Imaging. 2020;24(2):119-130. (In Russ.). https://doi.org/10.24835/1607-0763-2020-2-119-130
  13. Dobrynina LA, Gadzhieva ZSh, Morozova SN, et al. Executive functions of the brain: functional magnetic resonance imaging using the eschar test and the serial self-counting test in healthy subjects. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2018;118(11):64-73. (In Russ.).
  14. Scarpina F, Tagini S. The stroop color and word test. Front Psychol. 2017;8:1-8.  https://doi.org/10.3389/fpsyg.2017.00557
  15. Solovieva EYu, Kamchatnov PR, Novikova LB, et al. New possibilities for the treatment of mild cognitive impairment and prevention of dementia in patients with cerebrovascular disease. Results of the PRIORITET Observation Program. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2023;15(1):65-70. (In Russ.). https://doi.org/10.14412/2074-2711-2023-1-65-70
  16. Voznyuk IA, Zavadenko NN, Kamchatnov PR, et al. Results of the round table: modern approaches to drug therapy of cognitive impairment in cerebrovascular pathology. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2021;121(8):147-152. (In Russ.). https://doi.org/10.17116/jnevro2021121081147
  17. Belova AN, Bogdanov EI, Voznyuk IA, et al. Therapy of moderate cognitive disorders in the early recovery period of ischemic stroke. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2021;121(5):33-39. (In Russ.). https://doi.org/10.17116/jnevro202112105133
  18. Levin OS, Kovalchuk VV, Putilina MV, et al. Therapy of moderate cognitive impairment of various origins in patients with chronic somatic diseases: results of a multicenter open prospective observational program (PARUS). effective pharmacotherapy. Neurology and Psychiatry. 2022;18(43):78-83. (In Russ.).
  19. Shvartsman GI, Skoromets AA, Zhivolupov SA, et al. Therapy of moderate cognitive impairment and asthenia in patients with cerebrovascular disease: results of a multicenter open prospective observational program. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2022;122(8):82-88. (In Russ.). https://doi.org/10.17116/jnevro202212208188
  20. Yu JT, Xu W, Tan CC, et al. Evidence-based prevention of Alzheimer’s disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials. J Neurol Neurosurg Psychiatry. 2020;91:1201-1219.
  21. Eliassen CF, Reinvang I, Selnes P, et al. Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline. Brain Behav. 2017;7:e00776.
  22. Jessen F, Amariglio RE, Buckley RF, et al. The characterisation of subjective cognitive decline. Lancet Neurol. 2020;19:271-278. 
  23. Koberskaya NN, Tabeeva GR. The modern concept of cognitive reserve. Neurology, Neuropsychiatry, Psychosomatics. 2019;11(1):96-102. (In Russ.).
  24. Wallin A, Kapaki E, Boban M, et al. Biochemicalmarkers in vascular cognitive impairment associated with subcortical small vessel disease - a consensus report. BMC Neurol. 2017;17:102.  https://doi.org/10.1186/s12883-017-0877-3
  25. Wang R, Liu N, Tao Y, et al. The Application of rs-fMRI in Vascular Cognitive Impairment. Front Neurol. 2020;11.34(6):45-49.  https://doi.org/10.3389/fneur.2020.00951
  26. Farràs-Permanyer L, Guàrdia-Olmos J, Peró-Cebollero M. Mild cognitive impairment and fMRI studies of brain functional connectivity: the state of the art. Front Psychol. 2015;6:1095. https://doi.org/10.3389/fpsyg.2015.01095

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.